Form 4 for MRNA Moderna
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-05 · accession 0001682852-26-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-06 | 2026-03-05 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +11.8K | 71.5K | +20% | — |
| D | 2026-03-06 | 2026-03-05 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $57.80 | -5,704 | 65.8K | -8% | -$329.7K |
| D | 2026-03-06 | 2026-03-05 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -11.8K | 129.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | M | A | 11,797 | — | 71,486 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-03-05 | F | D | 5,704 | $57.80 | 65,782 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-03-05 | M | D | 11,797 | $0.00 | 129,774 | D | — · — to — | 11,797 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. |